Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVAS...

av Sabatier, Renaud, Pierga, Jean-Yves, Curé, Hervé, Abulnaja, Rakan, Lambaudie, Eric, Bidard, François-Clément, Extra, Jean-Marc, Sfumato, Patrick, Gonçalves, Anthony
I publikationen Cancers (Basel) (2021)

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

av Sabatier, Renaud, Charafe-Jauffret, Emmanuelle, Pierga, Jean-Yves, Curé, Hervé, Lambaudie, Eric, Genre, Dominique, Houvenaeghel, Gilles, Viens, Patrice, Ginestier, Christophe, Bertucci, François, Sfumato, Patrick, Extra, Jean-Marc, Gonçalves, Anthony
I publikationen J Clin Med (2019)

Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic prog...

av Garciaz, Sylvain, Sfumato, Patrick, Granata, Angela, Imbert, Anne-Marie, Fournel, Claire, Calmels, Boris, Lemarie, Claude, Chiaroni, Jacques, Blaise, Didier, Boher, Jean-Marie, Picard, Christophe, Chabannon, Christian, di Cristofaro, Julie
I publikationen PLoS One (2020)

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrela...

av Cheikh, Jean El, Sfumato, Patrick, Sobh, Mohamad, Fegueux, Nathalie, Mohty, Mohamad, Vigouroux, Stephane, Beguin, Yves, Yakoub-Agha, Ibrahim, Socié, Gerard, Cornillon, Jerome, Mercier, Melanie, Bay, Jacques Olivier, Blaise, Didier, Michallet, Mauricette, de Latour, Regis Peffault
I publikationen Haematologica (2016)

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

av Boudin, Laurys, Gonçalves, Anthony, Sfumato, Patrick, Sabatier, Renaud, Bertucci, François, Tarpin, Carole, Provansal, Magali, Houvenaeghel, Gilles, Lambaudie, Eric, Tallet, Agnes, Resbeut, Michel, Charafe-Jauffret, Emmanuelle, Calmels, Boris, Lemarie, Claude, Boher, Jean-Marie, Extra, Jean-Marc, Viens, Patrice, Chabannon, Christian
I publikationen J Cancer (2016)

Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials

av Vale, Claire L, Fisher, David J, Godolphin, Peter J, Rydzewska, Larysa H, Boher, Jean-Marie, Burdett, Sarah, Chen, Yu-Hui, Clarke, Noel W, Fizazi, Karim, Gravis, Gwenaelle, James, Nicholas D, Liu, Glenn, Matheson, David, Murphy, Laura, Oldroyd, Robert E, Parmar, Mahesh K B, Rogozinska, Ewelina, Sfumato, Patrick, Sweeney, Christopher J, Sydes, Matthew R, Tombal, Bertrand, White, Ian R, Tierney, Jayne F
I publikationen Lancet Oncol (2023)

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

av Bertucci, François, Gonçalves, Anthony, Guille, Arnaud, Adelaïde, José, Garnier, Séverine, Carbuccia, Nadine, Billon, Emilien, Finetti, Pascal, Sfumato, Patrick, Monneur, Audrey, Pécheux, Christophe, Khran, Martin, Brunelle, Serge, Mescam, Lenaïg, Thomassin-Piana, Jeanne, Poizat, Flora, Charafe-Jauffret, Emmanuelle, Turrini, Olivier, Lambaudie, Eric, Provansal, Magali, Extra, Jean-Marc, Madroszyk, Anne, Gilabert, Marine, Sabatier, Renaud, Vicier, Cécile, Mamessier, Emilie, Chabannon, Christian, Pakradouni, Jihane, Viens, Patrice, André, Fabrice, Gravis, Gwenaelle, Popovici, Cornel, Birnbaum, Daniel, Chaffanet, Max
I publikationen Genome Med (2021)